Research Article
In Silico Molecular Modeling Study on Isatin Derivatives as Anti-Covid Agents Based on Qsar and Docking Analysis
Author(s): Ganesh D. Mote*, Shubhangi S. Savale, Shubhangi S. Kharat and Aditya A. Bandgar
COVID 19 disease caused by novel SARS-CoV-2.It rapidly infects mammals and causes serious illness and death. The drug development against COVID 19 is a challenging task as COVID 19 disease spreads rapidly throughout the world. Drug development is a time-consuming process, but pandemics create an emergency to Design drugs as earlier as possible. In silico drug design is the key to fast-developing drug candidates. Corona virus’s main protease plays a vital function in the viral reproduction cycle and is a potential target for COVID 19 inhibitor development. Most of the Isatin derivatives show potential activity against COVID 19. All possible COVID-19 inhibitors were designed by using reference molecule and QSAR study. V life MDS software has the facility drug development techniques like 2D-QSAR MLR analysis and 3D-QSAR kNN analysis. We designed 50 new Chemical entities molecul.. Read More»
DOI:
10.4172/0975-413X.14.3.1-15
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report